Last data update: Aug 15, 2025. (Total: 49733 publications since 2009)
| Records 1-1 (of 1 Records) |
| Query Trace: Singleton JB[original query] |
|---|
| Perceptions and barriers to outpatient antiviral therapy for COVID-19 and influenza as observed by infectious disease specialists in North America: Results of an Emerging Infections Network (EIN) Survey, February 2024
Singleton JB , Wang D , Louis S , Smith DJ , Lambrou AS , Beekmann SE , Midgley CM , Polgreen P , Garg S , Ricaldi JN , Uyeki TM , Santibañez S , Patel P . Open Forum Infect Dis 2024 11 (12) ofae666 Antiviral therapy is underutilized for outpatients at increased risk for severe COVID-19 or influenza. Results from this survey offer insights into treatment barriers from the infectious disease specialist perspective. Further education is needed about the benefits of early antiviral therapy. |
- Page last reviewed:Feb 1, 2024
- Page last updated:Aug 15, 2025
- Content source:
- Powered by CDC PHGKB Infrastructure


